We are live on ! Find out more
RXIIW

RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021
RXIIW

Delisted

RXIIW was delisted on the 16th of November, 2018.

Back to rankings

4 hedge funds and large institutions have $401K invested in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

24% less capital invested

Capital invested by funds: $526K → $401K (-$125K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$458
2
CH
CVI Holdings
Delaware
-$19
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$255K – – –
CH
2
CVI Holdings
Delaware
$77K -$19 -41 -0%
SM
3
Sabby Management
Florida
$68K -$458 -963 -0.5%
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$1K – – –

RXIIW Hedge Fund Activity: Q3 2018 in Review

4 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) for Q3 2018, worth a combined $401K — down 24% from $526K a quarter earlier.

Fund positioning in RXIIW was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.

The largest seller was Sabby Management, cutting an estimated $458.

  • 4 institutional investors held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $401K of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 stock for Q3 2018, down 24% quarter-over-quarter.
  • 0 funds opened new RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 positions in Q3 2018 and 0 closed out.
  • The largest RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 seller in Q3 2018 was Sabby Management, an estimated $458 sold.

Based on aggregated 13F filings for Q3 2018.